DICP OpenIR
Tumor anti-angiogenic gene therapy with microencapsulated recombinant CHO cells
Zhang, Ying; Wang, Wei; Zhou, Jing; Yu, Weiting; Zhang, Xulang; Guo, Xin; Ma, Xiaojun; Ma XJ(马小军); Ma XJ(马小军)
关键词Microencapsulation Tumor Gene Therapy Endostatin Recombinant Cho Cells
刊名ANNALS OF BIOMEDICAL ENGINEERING
2007-04-01
ISSN0090-6964
DOI10.1007/s10439-007-9255-4
35期:4页:605-614
收录类别SCI
文章类型Article
部门归属18
项目归属1802
产权排名1;1
WOS标题词Science & Technology ; Technology
类目[WOS]Engineering, Biomedical
研究领域[WOS]Engineering
关键词[WOS]VIRUS-MEDIATED EXPRESSION ; DIABETES-MELLITUS ; ENDOTHELIAL-CELLS ; CARCINOMA GROWTH ; HUMAN ENDOSTATIN ; HEMOPHILIA-B ; CANCER ; MICE ; DELIVERY ; TECHNOLOGY
英文摘要Microencapsulation of recombinant cells is a novel promising approach to tumor therapy in which therapeutic protein is sustainable and long-term delivered by microencapsulated cells. The semi-permeable membrane of microcapsule can protect cell from host's immune rejection, increase the chemical stability of therapeutic protein and circumvent the problems of toxicity, limited half-lives and variation in circulating levels. Endostatin, a potent and specific angiogenesis inhibitor, could suppress the growth of primary and metastatic lesions in multiple murine tumor models. In this paper, APA microcapsules with high strength kept intact over 35 days and recombinant CHO cells kept the rapid proliferation viability and the continuous endostatin-expression function. The study of tumor treatment showed that the implantation of microencapsulated recombinant CHO cells decreased the neovascularization of tumor tissue by 59.4% and inhibited the B16 melanoma growth by 77.4%. Twenty days after tumor cell injection, 80% of animals treated with microencapsulated CHO-endo cells were alive compared to only 50% of animals in either control or mock control groups. Therefore, continuous delivery of endostatin from microencapsulated recombinant cells represents a feasible approach to tumor therapy.
语种英语
原文出处查看原文
WOS记录号WOS:000245078300009
引用统计
被引频次:14[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://cas-ir.dicp.ac.cn/handle/321008/98543
专题中国科学院大连化学物理研究所
通讯作者Ma XJ(马小军); Ma XJ(马小军)
作者单位1.Chinese Acad Sci, Dalian Inst Chem Phys, Lab Biomed Mat Engn, Dalian 116023, Peoples R China
2.Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China
推荐引用方式
GB/T 7714
Zhang, Ying,Wang, Wei,Zhou, Jing,et al. Tumor anti-angiogenic gene therapy with microencapsulated recombinant CHO cells[J]. ANNALS OF BIOMEDICAL ENGINEERING,2007,35(4):605-614.
APA Zhang, Ying.,Wang, Wei.,Zhou, Jing.,Yu, Weiting.,Zhang, Xulang.,...&马小军.(2007).Tumor anti-angiogenic gene therapy with microencapsulated recombinant CHO cells.ANNALS OF BIOMEDICAL ENGINEERING,35(4),605-614.
MLA Zhang, Ying,et al."Tumor anti-angiogenic gene therapy with microencapsulated recombinant CHO cells".ANNALS OF BIOMEDICAL ENGINEERING 35.4(2007):605-614.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhang, Ying]的文章
[Wang, Wei]的文章
[Zhou, Jing]的文章
百度学术
百度学术中相似的文章
[Zhang, Ying]的文章
[Wang, Wei]的文章
[Zhou, Jing]的文章
必应学术
必应学术中相似的文章
[Zhang, Ying]的文章
[Wang, Wei]的文章
[Zhou, Jing]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。